2018
Investigation of Dissolution Behavior HPMC/Eudragit®/Magnesium Aluminometasilicate Oral Matrices Based on NMR Solid-State Spectroscopy and Dynamic Characteristics of Gel Layer
NAISEROVÁ, M., Kateřina KUBOVÁ, Jakub VYSLOUŽIL, Sylvie PAVLOKOVÁ, David VETCHÝ et. al.Základní údaje
Originální název
Investigation of Dissolution Behavior HPMC/Eudragit®/Magnesium Aluminometasilicate Oral Matrices Based on NMR Solid-State Spectroscopy and Dynamic Characteristics of Gel Layer
Autoři
NAISEROVÁ, M. (203 Česká republika), Kateřina KUBOVÁ (203 Česká republika), Jakub VYSLOUŽIL (203 Česká republika, domácí), Sylvie PAVLOKOVÁ (203 Česká republika), David VETCHÝ (203 Česká republika), M. URBANOVÁ (203 Česká republika), J. BRUS (203 Česká republika), Jan VYSLOUŽIL (203 Česká republika, domácí) a P. KULICH (203 Česká republika)
Vydání
AAPS PHARMSCITECH, NEW YORK, SPRINGER, 2018, 1530-9932
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.608
Kód RIV
RIV/00216224:14310/18:00102251
Organizační jednotka
Přírodovědecká fakulta
UT WoS
000423720400017
Klíčová slova anglicky
matrix tablets HPMC Eudragit® NE30D Neusilin® US2 gel layer Levetiracetam Burst effect thermal treatment multivariate data analysis
Změněno: 23. 4. 2024 10:58, Mgr. Michal Petr
Anotace
V originále
Burst drug release is often considered a negative phenomenon resulting in unexpected toxicity or tissue irritation. Optimal release of a highly soluble active pharmaceutical ingredient (API) from hypromellose (HPMC) matrices is technologically impossible; therefore, a combination of polymers is required for burst effect reduction. Promising variant could be seen in combination of HPMC and insoluble Eudragits® as water dispersions. These can be applied only on API/insoluble filler mixture as over-wetting prevention. The main hurdle is a limited water absorption capacity (WAC) of filler. Therefore, the object of this study was to investigate the dissolution behavior of levetiracetam from HPMC/Eudragit®NE matrices using magnesium aluminometasilicate (Neusilin® US2) as filler with excellent WAC. Part of this study was also to assess influence of thermal treatment on quality parameters of matrices. The use of Neusilin® allowed the application of Eudragit® dispersion to API/Neusilin® mixture in one step during high-shear wet granulation. HPMC was added extragranularly. Obtained matrices were investigated for qualitative characteristics, NMR solid-state spectroscopy (ssNMR), gel layer dynamic parameters, SEM, and principal component analysis (PCA). Decrease in burst effect (max. of 33.6%) and dissolution rate, increase in fitting to zero-order kinetics, and paradoxical reduction in gel layer thickness were observed with rising Eudragit® NE concentration. The explanation was done by ssNMR, which clearly showed a significant reduction of the API particle size (150–500 nm) in granules as effect of surfactant present in dispersion in dependence on Eudragit®NE amount. This change in API particle size resulted in a significantly larger interface between these two entities. Based on ANOVA and PCA, thermal treatment was not revealed as a useful procedure for this system.